Back
Ticker avatar

Keros Therapeutics, Inc. KROS ยท SEC Filings

Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused o...
Price9.17
Market Cap179.96 M
Float11.47 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscripts
Search in Documents